SB273 Alabama 2025 Session

Summary

Primary Sponsor

April Weaver Senator

Republican

Session

2025 Regular Session

Title

Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug

Description

Existing law lists tetrahydrocannabinol (THC) as a Schedule I controlled substance, but explicitly exempts THC found in hemp.

Delta-8 THC, Delta-9 THC, and Delta-10 THC are psychoactive cannabinoids that can be made from hemp-derived cannabidiol (CBD). Under existing law, these psychoactive cannabinoids sold in Alabama may not be sold to minors and must be located in an area where minors cannot access the products.

This bill would provide that only nonpsychoactive cannabinoids derived from or found in hemp are exempt from the Schedule I controlled substances list, thus classifying psychoactive cannabinoids as controlled substances.

This bill would provide that products that are ingested, whether orally or absorbed through the skin, that contain cannabidiol (CBD) or other nonpsychoactive cannibinoids found in or derived from hemp may only be sold in licensed pharmacies that obtain certification from the Alabama State Board of Pharmacy.

This bill would require the Alabama State Board of Pharmacy to inspect pharmacies pursuant to this act.

This bill would require testing of consumable hemp products prior to sale.

SB273 INTRODUCED This bill would establish testing protocols for testing of hemp and consumable hemp products.

This bill would provide that only consumable hemp products using hemp cultivated in this state may be sold.

This bill would require the Department of Agriculture and Industries to establish a tracking program of hemp and consumable hemp products as well as the testing of these products.

This bill would also repeal the provision that prohibits the sale of psychoactive cannabinoids to minors.

Show more Show less

Subjects

Crimes & Offenses